IRF7 and systemic lupus erythematosus: Therefore, targeting Pin1-mediated production of type 1 IFN via TLR-7/TLR-9/IRAK-1/IRF-7 signaling may provide a promising novel therapeutic approach for SLE treatment and further studies are clearly warranted.